Skip to content

Sabin Karki

Primary Navigation

  • Healthcare
  • Finance/Investing
  • Global
  • Pictures

About me

Sabin Karki

Sabin Karki

I'm a student at Johns Hopkins University studying Biomedical Engineering and Entrepreneurship & Management with a focus in Imaging & Medical Devices. Medical device inventor and aspiring physician innovator. CEO/co-founder of Benegraft, a team of engineers, surgeons, and technologists developing next-generation surgical tools for better outcomes and more efficient procedures in the reconstructive surgery space. I aspire to combine my passions for medical innovation, tech, finance, and policy to improve healthcare delivery at both a point-of-care and systemic level. My mission is to work toward a world with accessible, affordable, and high-quality healthcare for all. Find my latest thoughts on topics in medicine, investing, and more at www.sabinkarki.com Email: skarki5@jhu.edu Social: linkedin.com/in/sabinkarki IG: @sabincarkey

View Full Profile →

Contact

skarki5@jhu.edu

Category: Finance/Investing

Electronic Exploitation
Finance/Investing

Electronic Exploitation

In May of 2010, as the nation reeled from the global financial crisis that struck just two years earlier, markets … Continue reading Electronic Exploitation

Amid Market Turmoils, Huntington Ingalls Remains Steady
Finance/Investing

Amid Market Turmoils, Huntington Ingalls Remains Steady

As investors turn toward stabler companies amid the heightened market volatility in recent months, one corporation which should not be ignored … Continue reading Amid Market Turmoils, Huntington Ingalls Remains Steady

Can LifeLock Still Lock in Profits?
Finance/Investing

Can LifeLock Still Lock in Profits?

No one can deny that LifeLock, Inc., the $1.2 billion company at the forefront of data protection and identity theft … Continue reading Can LifeLock Still Lock in Profits?

The Exchange: Criteo, Standing in the Shadows of Giants
Finance/Investing

The Exchange: Criteo, Standing in the Shadows of Giants

You may not have heard of Criteo–but chances are, it’s probably heard of you. Criteo (NASDAQ: CRTO) isn’t the latest … Continue reading The Exchange: Criteo, Standing in the Shadows of Giants

Create a website or blog at WordPress.com
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Follow Following
    • Sabin Karki
    • Already have a WordPress.com account? Log in now.
    • Sabin Karki
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar